162 related articles for article (PubMed ID: 14734749)
1. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).
Clemenza L; Isenman DE
J Immunol; 2004 Feb; 172(3):1670-80. PubMed ID: 14734749
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
Reilly BD; Mold C
Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
[TBL] [Abstract][Full Text] [Related]
3. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4.
Gibb AL; Freeman AM; Smith RA; Edmonds S; Sim E
Biochim Biophys Acta; 1993 Jan; 1180(3):313-20. PubMed ID: 8422437
[TBL] [Abstract][Full Text] [Related]
4. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
Gatenby PA; Barbosa JE; Lachmann PJ
Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
[TBL] [Abstract][Full Text] [Related]
6. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.
Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY
Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523
[TBL] [Abstract][Full Text] [Related]
7. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
8. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
[TBL] [Abstract][Full Text] [Related]
9. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T
Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055
[TBL] [Abstract][Full Text] [Related]
10. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.
Isenman DE; Young JR
J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717
[TBL] [Abstract][Full Text] [Related]
11. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
[TBL] [Abstract][Full Text] [Related]
12. [Isotyping of human C4 complement using differences in the functional activity of C4A and C4B isotypes].
Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
Bioorg Khim; 2000 Jul; 26(7):539-47. PubMed ID: 11008645
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human C4A and C4B binding to an immune complex in serum.
Reilly BD
Clin Exp Immunol; 1999 Jul; 117(1):12-8. PubMed ID: 10403910
[TBL] [Abstract][Full Text] [Related]
14. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
Sepp A; Dodds AW; Anderson MJ; Campbell RD; Willis AC; Law SK
Protein Sci; 1993 May; 2(5):706-16. PubMed ID: 8495193
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
16. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
von Zabern I; Bloom EL; Chu V; Gigli I
J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
[TBL] [Abstract][Full Text] [Related]
17. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity.
Yu CY; Belt KT; Giles CM; Campbell RD; Porter RR
EMBO J; 1986 Nov; 5(11):2873-81. PubMed ID: 2431902
[TBL] [Abstract][Full Text] [Related]
19. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4B.
Reilly BD; Levine P; Rothbard J; Skanes VM
Complement Inflamm; 1991; 8(1):33-42. PubMed ID: 2049934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
